Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countries.

Autor: Rylance S; Noncommunicable Diseases Department, World Health Organization, Geneva, Switzerland., Bateman ED; Global Initiative for Asthma (GINA), Fontana, WI, USA, University of Cape Town Lung Institute, Cape Town, South Africa., Boulet L; Global Initiative for Asthma (GINA), Fontana, WI, USA, Laval University, Quebec City, QC, Canada., Cohen M; Forum of International Respiratory Societies, Lausanne, Switzerland, Asociacion Latinoamericana de Torax, Montevideo, Uruguay, Hospital Centro Medico, Guatemala City, Guatemala., El Sony A; International Union Against Tuberculosis and Lung Disease, Paris, France, Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum, Sudan., Halpin DMG; Global Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, University of Exeter Medical School, Exeter, UK., Khoo EM; International Primary Care Respiratory Group (IPCRG), Edinburgh, UK, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia., Marks GB; International Union Against Tuberculosis and Lung Disease, Paris, France, University of New South Wales, Sydney, NSW, Australia., Masekela R; International Union Against Tuberculosis and Lung Disease, Paris, France, Global Asthma Network (GAN), Auckland, New Zealand, Pan African Thoracic Society, Congella, South Africa, Department of Paediatrics and Child Health, University of KwaZulu Natal, Durban, South Africa., Mikkelsen B; Noncommunicable Diseases Department, World Health Organization, Geneva, Switzerland., Mortimer KJ; Global Initiative for Asthma (GINA), Fontana, WI, USA, International Union Against Tuberculosis and Lung Disease, Paris, France, Global Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, Global Asthma Network (GAN), Auckland, New Zealand, Aintree University Hospital, Liverpool, UK., Chakaya Muhwa J; International Union Against Tuberculosis and Lung Disease, Paris, France, Kenyatta University, Nairobi, Kenya., Nunes da Cunha I; International Pharmaceutical Federation, The Hague, Netherlands., Šajnić A; International Coalition of Respiratory Nurses, University Hospital Centre Zagreb, Croatia., Salvi S; Global Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, Pulmocare Research and Education Foundation, Pune, India., Slama S; Noncommunicable Diseases Department, World Health Organization, Geneva, Switzerland., Winders T; Global Allergy and Airways Patient Platform, Vienna, Austria., Yorgancioglu A; Global Initiative for Asthma (GINA), Fontana, WI, USA, Celal Bayar University, Manisa, Turkey., Zar HJ; Forum of International Respiratory Societies, Lausanne, Switzerland, Pan African Thoracic Society, Congella, South Africa, SA Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2022 Dec 01; Vol. 26 (12), pp. 1106-1108.

Measuring Air Quality for Advocacy in Africa (MA3): Feasibility and Practicality of Longitudinal Ambient PM 2.5 Measurement Using Low-Cost Sensors.

Autor: Awokola BI; Centre for Health Informatics, Computing & Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster LA1 4YW, UK.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.; Department of Clinical Services, Medical Research Council Gambia at London School of Hygiene & Tropical Medicine, P. O. Box 273 Banjul, ‎Gambia., Okello G; Institute for Sustainability Leadership, University of Cambridge, 2 Trumpington Street, Cambridge CB2 1QA, UK.; African Centre for Clean Air, P.O. Box 4357 Kampala, Uganda., Mortimer KJ; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.; Respiratory Medicine Department, Aintree University Hospital NHS Foundation Trust, Liverpool L9 7AL, UK., Jewell CP; Centre for Health Informatics, Computing & Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster LA1 4YW, UK., Erhart A; Disease Control & Elimination Theme, Medical Research Council Gambia at London School of Hygiene & Tropical Medicine, P. O. Box 273 Banjul, ‎Gambia., Semple S; Institute for Social Marketing and Health, University of Stirling, Stirling FK9 4LA, UK.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Oct 03; Vol. 17 (19). Date of Electronic Publication: 2020 Oct 03.

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Autor: Mortimer KJ; Division of Respiratory Medicine, University of Nottingham, UK. kevinmortimer@msn.com, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2007 Oct; Vol. 64 (4), pp. 439-44. Date of Electronic Publication: 2007 Aug 15.

Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.

Autor: Mortimer KJ; Division of Respiratory Medicine, Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. kevin.mortimer@nottingham.ac.uk, Tattersfield AE

Publikováno v: Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2005 Aug; Vol. 25 (3), pp. 523-39.